Commonwealth Equity Services’s BioTelemetry, Inc. BEAT Stock Holding History

Commonwealth Equity Services’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-3,028	Closed	-$218K	–	3510
2020 Q4	$218K	Buy	+3,028	New	+$159K	﹤0.01%	2847
2019 Q2	–	Sell	-5,162	Closed	-$323K	–	2864
2019 Q1	$323K	Buy	5,162 +1,746	+51%	+$120K	﹤0.01%	2097
2018 Q4	$204K	Sell	3,416 -1,388	-29%	-$83.3K	﹤0.01%	2317
2018 Q3	$309K	Buy	+4,804	New	+$268K	﹤0.01%	2151

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Commonwealth Equity Services's BEAT Position: Q1 2021 in Review

Commonwealth Equity Services sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 3,028 shares — an estimated $218K sold.

Commonwealth Equity Services first reported a position in BEAT in Q3 2018 and held it in 4 quarters. The position peaked at $323K in Q1 2019. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Commonwealth Equity Services reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Commonwealth Equity Services sold 3,028 BioTelemetry, Inc. shares in Q1 2021, an estimated $218K.
Commonwealth Equity Services first reported a position in BioTelemetry, Inc. in Q3 2018 and held it in 4 quarters.
Commonwealth Equity Services's BioTelemetry, Inc. position peaked at $323K in Q1 2019.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Commonwealth Equity Services's 13F filing for Q1 2021, filed 4 May 2021.